back to open calls

Biomedical catalyst 2021: early and late stage awards

Opens:
7/6/2021
Closes:
26/8/2021
Sectors:
Health & Life Sciences
All
Project Size:
£250,000 - £4 million

Summary

UK registered businesses can apply for a share of up to £18 million to develop innovative healthcare products, technologies and processes. This funding is from Innovate UK, part of UK Research and Innovation.

Your project can address:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

This list is not intended to be exhaustive.

This competition combines the early and late-stage strands of the Biomedical Catalyst.

Equality, diversity and inclusion (EDI) considerations are highly encouraged where appropriate in the proposal. Applications will continue to be assessed on their innovation merit, where innovation is defined as the potential for commercially successful exploitation of ideas.

In applying to this competition, you are entering into a competitive process This competition closes at 11am UK time on the date of the deadline.

 

Eligibility

Your project must:

  • Your project must:
  • have total eligible costs between £250,000 and £4 million
  • start from 1 April 2022
  • last between 12 months and 36 months

 To lead a project or work alone your organisation must:

To collaborate with the lead, your organisation must:

Scope

The aim of this early and late-stage competition is to enable businesses to create a data package that can support the further development of their products. 

The project can include:

  • experimental evaluation (at laboratory scale)
  • use of in vitro and in vivo models to evaluate proof of concept or safety
  • exploring potential production mechanisms
  • proyotyping
  • product development planning
  • intellectual property protection
  • demonstrating of clinical utility and effectiveness
  • demonstrating of safety and efficacy (including phase 1 and 2 clinical trials)
  • regulatory planning

Your project must focus on the development of a product or process that is an innovative solution to a defined health or care challenge.

 This competition combines the early and late-stage strands of the Biomedical Catalyst.

  •  Early-stage - The aim of an early-stage award is to create a data package that is sufficient to support the testing of your product or process in a clinical setting or other relevant environment.
  • Late-stage - The late-stage award is designed to test a well-developed concept and show its effectiveness in a clinical setting or other relevant environment.

 Your project must build on prior credible research on a product prototype or process. This is likely to have included a demonstration or validation in an appropriate model system.



Interested in this call? Book a free consultation with our team
Book a Consultation
+44 (0) 1925 506 100
Contact Us
Thank you! We will be in touch shortly.
Oops! Something went wrong while submitting the form.